Rakshak Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -0.05%
(FY 2023)
- Profit -416.34%
(FY 2023)
- Ebitda 47.05%
(FY 2023)
- Net Worth -76.81%
(FY 2023)
- Total Assets -58.45%
(FY 2023)
About Rakshak Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunita Patil and Snehal Sonwalkar serve as directors at the Company.
- CIN/LLPIN
U85190PN2020PTC191860
- Company No.
191860
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rakshak Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunita Patil  | Director | 10-Jul-2020 | Current |
| Snehal Sonwalkar | Director | 10-Jul-2020 | Current |
Financial Performance and Corporate Structure Insights of Rakshak Lifescience.
Rakshak Lifescience Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.05% decrease. The company also saw a substantial fall in profitability, with a 416.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 76.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rakshak Lifescience?
Unlock access to Rakshak Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Rakshak Developers And Infra Private LimitedActive 14 years 2 months
Sunita Patil is a mutual person
- Rakshak Security Services And Systems Private LimitedActive 14 years 2 months
Sunita Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rakshak Lifescience?
Rakshak Lifescience has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rakshak Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rakshak Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
